Cosmic Implications of NXY-059
- 1 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (3_suppl_1), S115-8
- https://doi.org/10.1161/strokeaha.108.535112
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study QualityStroke, 2008
- Spreading depolarizations occur in human ischemic stroke with high incidenceAnnals of Neurology, 2008
- The 2007 Feinberg LectureStroke, 2008
- NXY-059 for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 2007
- Role of drug efflux carriers in the healthy and diseased brainAnnals of Neurology, 2006
- Functional and Histological Evidence for the Protective Effect of NXY-059 in a Primate Model of Stroke When Given 4 Hours After OcclusionStroke, 2003
- Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of StrokeStroke, 2003
- Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N -Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke ModelStroke, 2002
- Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced HypothermiaNew England Journal of Medicine, 2002
- Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac ArrestNew England Journal of Medicine, 2002